|
US4217344A
(en)
|
1976-06-23 |
1980-08-12 |
L'oreal |
Compositions containing aqueous dispersions of lipid spheres
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4186183A
(en)
|
1978-03-29 |
1980-01-29 |
The United States Of America As Represented By The Secretary Of The Army |
Liposome carriers in chemotherapy of leishmaniasis
|
|
US4261975A
(en)
|
1979-09-19 |
1981-04-14 |
Merck & Co., Inc. |
Viral liposome particle
|
|
US4485054A
(en)
|
1982-10-04 |
1984-11-27 |
Lipoderm Pharmaceuticals Limited |
Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US4946787A
(en)
|
1985-01-07 |
1990-08-07 |
Syntex (U.S.A.) Inc. |
N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US5049386A
(en)
|
1985-01-07 |
1991-09-17 |
Syntex (U.S.A.) Inc. |
N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4897355A
(en)
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4774085A
(en)
|
1985-07-09 |
1988-09-27 |
501 Board of Regents, Univ. of Texas |
Pharmaceutical administration systems containing a mixture of immunomodulators
|
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5549910A
(en)
|
1989-03-31 |
1996-08-27 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
WO1991017424A1
(en)
|
1990-05-03 |
1991-11-14 |
Vical, Inc. |
Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
|
|
JP3218637B2
(ja)
|
1990-07-26 |
2001-10-15 |
大正製薬株式会社 |
安定なリポソーム水懸濁液
|
|
JP2958076B2
(ja)
|
1990-08-27 |
1999-10-06 |
株式会社ビタミン研究所 |
遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
|
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
US5589362A
(en)
|
1993-06-14 |
1996-12-31 |
Basf Aktiengesellschaft |
Tetracycline regulated transcriptional modulators with altered DNA binding specificities
|
|
JPH09500526A
(ja)
|
1993-06-14 |
1997-01-21 |
ベーアーエスエフ アクツィエンゲゼルシャフト |
テトラサイクリン反応性プロモーターによる真核細胞の遺伝子発現の厳密な制御
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US5651981A
(en)
|
1994-03-29 |
1997-07-29 |
Northwestern University |
Cationic phospholipids for transfection
|
|
US5741516A
(en)
|
1994-06-20 |
1998-04-21 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
|
AU746850B2
(en)
|
1994-07-01 |
2002-05-02 |
Tet Systems Holding Gmbh & Co. Kg |
Tetracycline-regulated transcriptional modulaters
|
|
US5767099A
(en)
|
1994-12-09 |
1998-06-16 |
Genzyme Corporation |
Cationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic molecules
|
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
|
IE80468B1
(en)
|
1995-04-04 |
1998-07-29 |
Elan Corp Plc |
Controlled release biodegradable nanoparticles containing insulin
|
|
US5851548A
(en)
|
1995-06-07 |
1998-12-22 |
Gen-Probe Incorporated |
Liposomes containing cationic lipids and vitamin D
|
|
US5738868A
(en)
|
1995-07-18 |
1998-04-14 |
Lipogenics Ltd. |
Liposome compositions and kits therefor
|
|
US5928941A
(en)
|
1996-10-07 |
1999-07-27 |
President And Fellows Of Harvard College |
Repressor kruppel-like factor
|
|
DE19818620A1
(de)
|
1998-04-21 |
1999-10-28 |
Metagen Gesellschaft Fuer Genomforschung Mbh |
Menschliche Nukleinsäuresequenzen aus Blase-Normal
|
|
DE19851415B4
(de)
|
1998-11-07 |
2010-11-04 |
Wolfgang Hillen |
Mutanter Transaktivator
|
|
US20080050393A1
(en)
|
1998-12-03 |
2008-02-28 |
Tang Y Tom |
Novel nucleic acids and polypeptides
|
|
US7364868B2
(en)
|
1999-05-19 |
2008-04-29 |
The Uab Research Foundation |
Krüppel-like transcriptional factor KLF4/GKLF and uses thereof
|
|
WO2000069450A1
(en)
|
1999-05-19 |
2000-11-23 |
The Uab Research Foundation |
Oncogene identification by transformation of rk3e cells and uses thereof
|
|
US20030138799A1
(en)
|
1999-05-19 |
2003-07-24 |
Ruppert J. Michael |
Oncogene identification by transformation of RK3E cells and uses thereof
|
|
AU783233B2
(en)
|
1999-06-07 |
2005-10-06 |
Tet Systems Holding Gmbh & Co. Kg |
Novel TET repressor-based transcriptional regulatory proteins
|
|
US20110171185A1
(en)
|
1999-06-30 |
2011-07-14 |
Klimanskaya Irina V |
Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof
|
|
US20030165921A1
(en)
|
2000-02-03 |
2003-09-04 |
Tang Y. Tom |
Novel nucleic acids and polypeptides
|
|
US20070042392A1
(en)
|
2000-02-03 |
2007-02-22 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
|
CA2399776A1
(en)
|
2000-02-03 |
2001-08-09 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
|
EP1358349A2
(en)
|
2000-06-05 |
2003-11-05 |
Avalon Pharmaceuticals |
Cancer gene determination and therapeutic screening using signature gene sets
|
|
US20020165180A1
(en)
|
2000-09-18 |
2002-11-07 |
Zoe Weaver |
Process for identifying anti-cancer therapeutic agents using cancer gene sets
|
|
US20050064454A1
(en)
|
2000-06-05 |
2005-03-24 |
Young Paul E. |
Cancer gene determination and therapeutic screening using signature gene sets
|
|
US6750015B2
(en)
|
2000-06-28 |
2004-06-15 |
Kathryn B. Horwitz |
Progesterone receptor-regulated gene expression and methods related thereto
|
|
CA2325088A1
(en)
|
2000-12-01 |
2002-06-01 |
Fusogenix Inc. |
Novel membrane fusion proteins derived from poikilothermic reovirus
|
|
US20030065157A1
(en)
|
2001-04-04 |
2003-04-03 |
Lasek Amy W. |
Genes expressed in lung cancer
|
|
US20070060743A1
(en)
|
2001-05-16 |
2007-03-15 |
Tang Y Tom |
Novel nucleic acids and polypeptides
|
|
WO2003012113A2
(en)
|
2001-08-02 |
2003-02-13 |
Gencell S.A. |
Inducible expression systems employing ppar transcriptional activators
|
|
NZ532635A
(en)
|
2001-11-13 |
2007-05-31 |
Univ Pennsylvania |
A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
|
|
US20030186281A1
(en)
|
2001-12-21 |
2003-10-02 |
Wolfgang Hillen |
Modified tetracycline repressor protein compositions and methods of use
|
|
JP2004121218A
(ja)
|
2002-08-06 |
2004-04-22 |
Jenokkusu Soyaku Kenkyusho:Kk |
気管支喘息または慢性閉塞性肺疾患の検査方法
|
|
JP2006516192A
(ja)
|
2002-10-18 |
2006-06-29 |
ジェネンテック・インコーポレーテッド |
腫瘍の診断と治療のための組成物と方法
|
|
CA2503390A1
(en)
|
2002-11-01 |
2004-05-21 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
EP1572116A4
(en)
|
2002-11-26 |
2007-12-12 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
|
|
WO2004073657A2
(en)
|
2003-02-19 |
2004-09-02 |
Protein Design Labs, Inc. |
Methods of diagnosis of cancer and other diseases, composition and methods of screening for modulators of cancer and other diseases
|
|
GB0327384D0
(en)
|
2003-11-25 |
2003-12-31 |
Queen Mary & Westfield College |
Gene therapy
|
|
US7682828B2
(en)
|
2003-11-26 |
2010-03-23 |
Whitehead Institute For Biomedical Research |
Methods for reprogramming somatic cells
|
|
WO2006023207A2
(en)
|
2004-08-19 |
2006-03-02 |
The United States Of America As Represented By The Secretary Of Health And Human Services, Nih |
Coacervate of anionic and cationic polymer forming microparticles for the sustained release of therapeutic agents
|
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
|
US20070072175A1
(en)
|
2005-05-13 |
2007-03-29 |
Biogen Idec Ma Inc. |
Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
|
|
WO2006123930A2
(en)
|
2005-05-20 |
2006-11-23 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Nucleic acids and polypeptides that are useful in controlling neuronal regeneration
|
|
US20100190250A1
(en)
*
|
2005-10-14 |
2010-07-29 |
Jifan Hu |
Methods of Rejuvenating Cells In Vitro and In Vivo
|
|
JP5155176B2
(ja)
|
2005-11-17 |
2013-02-27 |
ティーイーティー システムズ ゲーエムベーハー ウント ツェーオー． カーゲー |
誘導発現系
|
|
USRE49583E1
(en)
|
2005-11-17 |
2023-07-18 |
Tet Systems Gmbh & Co. Kg |
Inducible expression systems
|
|
US8278104B2
(en)
*
|
2005-12-13 |
2012-10-02 |
Kyoto University |
Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
|
|
WO2007078599A2
(en)
|
2005-12-16 |
2007-07-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Functional arrays for high throughput characterization of gene expression regulatory elements
|
|
US20070161031A1
(en)
|
2005-12-16 |
2007-07-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Functional arrays for high throughput characterization of gene expression regulatory elements
|
|
WO2008100328A2
(en)
*
|
2006-07-13 |
2008-08-21 |
Burnham Institute For Medical Research |
METHODS AND COMPOSITIONS FOR TARGETING gC1qR/p32
|
|
WO2008051854A2
(en)
|
2006-10-20 |
2008-05-02 |
Trustees Of Boston University |
A tunable genetic switch for regulating gene expression
|
|
US8080647B2
(en)
|
2006-11-22 |
2011-12-20 |
Pioneer Hi Bred International Inc |
Tetracycline repressor and uses thereof
|
|
WO2008081435A2
(en)
|
2006-12-29 |
2008-07-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for predicting prognosis of multiple sclerosis
|
|
US9243226B2
(en)
|
2007-02-23 |
2016-01-26 |
University Of Central Florida Research Foundation, Inc. |
Biasing of cells toward retinal, corneal or lens development
|
|
WO2008105630A1
(en)
|
2007-02-27 |
2008-09-04 |
Procell Therapeutics Inc. |
Combined use of cell permeable nanog and oct4 for increasing self-renewal and suppressing differentiation of stem cells
|
|
JP2010537629A
(ja)
|
2007-08-30 |
2010-12-09 |
アカデミシュ ジーケンハウス ビイ デ ユニヴェアズィテート ファン アムステルダム |
動脈形成に関与する経路及びその使用
|
|
AU2008297024B2
(en)
|
2007-10-31 |
2014-08-28 |
Kyoto University |
Nuclear reprogramming method
|
|
US20110151447A1
(en)
|
2007-11-06 |
2011-06-23 |
Children's Medical Center Corporation |
Method to produce induced pluripotent stem (ips) cells from non-embryonic human cells
|
|
WO2009067563A1
(en)
|
2007-11-19 |
2009-05-28 |
The Regents Of The University Of California |
Generation of pluripotent cells from fibroblasts
|
|
WO2009067757A1
(en)
|
2007-11-30 |
2009-06-04 |
Cytomatrix Pty Ltd |
Methods of inducing pluripotency involving oct4 protein
|
|
AU2008329562A1
(en)
|
2007-11-30 |
2009-06-04 |
Cytomatrix Pty Ltd |
Methods of inducing pluripotency involving Sox2 protein
|
|
EP2103685A1
(en)
|
2008-03-20 |
2009-09-23 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Vectors and methods for generating vector-free induced pluripotent stem (iPS) cells using site-specific recombination
|
|
US20110061118A1
(en)
|
2008-03-17 |
2011-03-10 |
Helmholtz Zentrum Munchen |
Vectors and methods for generating vector-free induced pluripotent stem (ips) cells using site-specific recombination
|
|
CN101302553A
(zh)
|
2008-05-30 |
2008-11-12 |
广州华峰生物科技有限公司 |
基于环介导等温扩增技术的结核分歧杆菌基因快速诊断试剂盒及其检测方法
|
|
EP3279314A1
(en)
|
2008-06-04 |
2018-02-07 |
Cellular Dynamics International, Inc. |
Methods for the production of ips cells using non-viral approach
|
|
EP3231869A1
(en)
|
2008-06-13 |
2017-10-18 |
Whitehead Institute for Biomedical Research |
Programming and reprogramming of cells
|
|
US9127256B2
(en)
|
2008-07-16 |
2015-09-08 |
Dnavec Corporation |
Method for production of reprogrammed cell using chromosomally unintegrated virus vector
|
|
JP2012500005A
(ja)
|
2008-08-12 |
2012-01-05 |
セルラー ダイナミクス インターナショナル， インコーポレイテッド |
ｉＰＳ細胞を生成するための方法
|
|
US8790664B2
(en)
|
2008-09-05 |
2014-07-29 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Multimodular assembly useful for intracellular delivery
|
|
WO2010030003A1
(ja)
|
2008-09-12 |
2010-03-18 |
協和発酵キリン株式会社 |
細胞のリプログラミングに用いられる複数遺伝子の発現制御システム
|
|
US8636884B2
(en)
|
2008-09-15 |
2014-01-28 |
Abbott Diabetes Care Inc. |
Cationic polymer based wired enzyme formulations for use in analyte sensors
|
|
EP2191840A1
(en)
|
2008-11-28 |
2010-06-02 |
Sanofi-Aventis |
Antitumor combinations containing antibodies recognizing specifically CD38 and melphalan
|
|
CA2688804A1
(en)
|
2008-12-17 |
2010-06-17 |
The Uab Research Foundation |
Polycistronic vector for human induced pluripotent stem cell production
|
|
JP2012513218A
(ja)
|
2008-12-23 |
2012-06-14 |
ヴィヴォスクリプト，インコーポレイテッド |
遺伝子改変を伴わずに細胞を再プログラミングするための組成物および方法
|
|
CN102439045A
(zh)
|
2009-03-12 |
2012-05-02 |
株式会社普罗赛尔制药 |
利用可穿透细胞的重编程转录因子建立诱导性多能干细胞用于个性化干细胞疗法
|
|
KR20110134939A
(ko)
|
2009-04-03 |
2011-12-15 |
더 맥클린 하스피털 코퍼레이션 |
유도된 다능성 줄기 세포
|
|
US10837020B2
(en)
|
2009-04-22 |
2020-11-17 |
Massachusetts Institute Of Technology |
Innate immune suppression enables repeated delivery of long RNA molecules
|
|
US20100273220A1
(en)
|
2009-04-22 |
2010-10-28 |
Massachusetts Institute Of Technology |
Innate immune suppression enables repeated delivery of long rna molecules
|
|
WO2010135329A2
(en)
|
2009-05-18 |
2010-11-25 |
Curna, Inc. |
Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
US8569256B2
(en)
|
2009-07-01 |
2013-10-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
|
CN101993495B
(zh)
|
2009-08-12 |
2013-07-24 |
上海近岸科技有限公司 |
一种蛋白质混合物及其制备方法
|
|
JP5514215B2
(ja)
|
2009-08-31 |
2014-06-04 |
国立大学法人大阪大学 |
口腔粘膜由来細胞を利用した誘導多能性幹細胞の効率的な製造方法
|
|
JP2013505232A
(ja)
|
2009-09-16 |
2013-02-14 |
スティヒティング ヘット ネーデルラント カンカー インスティテュート |
癌治療のための薬剤標的としてのＦｒａ−１標的遺伝子
|
|
US8326547B2
(en)
|
2009-10-07 |
2012-12-04 |
Nanjingjinsirui Science & Technology Biology Corp. |
Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm
|
|
WO2011068916A1
(en)
|
2009-12-01 |
2011-06-09 |
Intezyne Technologies, Incorporated |
Pegylated polyplexes for polynucleotide delivery
|
|
CA2796464C
(en)
|
2010-04-16 |
2021-08-03 |
Immune Disease Institute, Inc. |
Sustained polypeptide expression from synthetic, modified rnas and uses thereof
|
|
WO2011145615A1
(ja)
|
2010-05-18 |
2011-11-24 |
タカラバイオ株式会社 |
多能性幹細胞の製造のための核酸
|
|
GB201008267D0
(en)
|
2010-05-18 |
2010-06-30 |
Univ Edinburgh |
Cationic lipids
|
|
EP2388336A1
(en)
|
2010-05-19 |
2011-11-23 |
Signature Diagnostics AG |
Method and kits for diagnosing colorectal cancer
|
|
US8748667B2
(en)
|
2010-06-04 |
2014-06-10 |
Sirna Therapeutics, Inc. |
Low molecular weight cationic lipids for oligonucleotide delivery
|
|
WO2012012708A1
(en)
|
2010-07-22 |
2012-01-26 |
Regents Of The University Of Minnesota |
Induced pluripotent stem cells
|
|
WO2012014207A2
(en)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
|
|
CA2809515A1
(en)
|
2010-08-30 |
2012-03-08 |
Dnavec Corporation |
Composition for inducing pluripotent stem cell, and use thereof
|
|
AU2011305572B2
(en)
|
2010-09-20 |
2016-08-04 |
Diane Goll |
Microencapsulation process and product
|
|
WO2012040825A1
(en)
|
2010-09-29 |
2012-04-05 |
Innovascreen Inc. |
Recombinant polypeptides for membrane fusion and uses thereof
|
|
EP3260540A1
(en)
|
2010-11-12 |
2017-12-27 |
The General Hospital Corporation |
Polycomb-associated non-coding rnas
|
|
EP2643459B1
(en)
|
2010-11-24 |
2017-09-27 |
Takara Bio USA, Inc. |
Inducible expression system transcription modulators comprising a distributed protein transduction domain and methods for using the same
|
|
CN103327970A
(zh)
|
2010-11-26 |
2013-09-25 |
约翰内斯堡威特沃特斯兰德大学 |
聚合物-脂质纳米粒子的聚合基质作为药物剂型
|
|
KR101255338B1
(ko)
|
2010-12-15 |
2013-04-16 |
포항공과대학교 산학협력단 |
표적 세포에 대한 폴리뉴클레오티드 전달체
|
|
WO2012083017A2
(en)
|
2010-12-16 |
2012-06-21 |
Celgene Corporation |
Controlled release oral dosage forms of poorly soluble drugs and uses thereof
|
|
DK2655621T3
(en)
|
2010-12-20 |
2018-08-13 |
Massachusetts Gen Hospital |
Polycomb-associated non-coding RNAS
|
|
US9228204B2
(en)
|
2011-02-14 |
2016-01-05 |
University Of Utah Research Foundation |
Constructs for making induced pluripotent stem cells
|
|
WO2012112603A1
(en)
|
2011-02-14 |
2012-08-23 |
University Of Utah Research Foundations |
Constructs and methods for generating induced pluri potent stem ( ips) cells
|
|
DE102011005235B4
(de)
|
2011-03-08 |
2017-05-24 |
Sirs-Lab Gmbh |
Verfahren zum Identifizieren einer Teilmenge von Polynucleotiden aus einer dem Humangenom entsprechenden Ausgangsmenge von Polynucleotiden zur in vitro Bestimmung eines Schweregrads der Wirtsantwort eines Patienten
|
|
US8709466B2
(en)
|
2011-03-31 |
2014-04-29 |
International Business Machines Corporation |
Cationic polymers for antimicrobial applications and delivery of bioactive materials
|
|
JP6584776B2
(ja)
*
|
2011-04-08 |
2019-10-02 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
細胞を幼若化するための方法
|
|
US10092660B2
(en)
|
2011-04-25 |
2018-10-09 |
Stc.Unm |
Solid compositions for pharmaceutical use
|
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
|
EP2710130B1
(en)
|
2011-05-19 |
2022-06-29 |
Fundación Pública Andaluza Progreso Y Salud |
Highly inducible dual-promoter lentiviral tet-on system
|
|
US9862926B2
(en)
*
|
2011-06-27 |
2018-01-09 |
Cellscript, Llc. |
Inhibition of innate immune response
|
|
GB201118964D0
(en)
|
2011-11-03 |
2011-12-14 |
Ucl Business Plc |
Method
|
|
WO2013139429A1
(en)
|
2012-03-21 |
2013-09-26 |
Merck Patent Gmbh |
Induced neural stem cells
|
|
EP2836577B1
(en)
|
2012-04-11 |
2017-06-07 |
The Lubrizol Corporation |
Dispersants derived from hydroxy fatty acid polyesters and polyalkylene glycol dispersants
|
|
CN104508131B
(zh)
|
2012-05-21 |
2018-11-23 |
加利福尼亚大学董事会 |
通过合成的自我复制的RNA形成人iPS细胞
|
|
WO2013177228A1
(en)
|
2012-05-22 |
2013-11-28 |
Loma Linda University |
Generation of integration/transgene-free stem cells
|
|
EP2669381A1
(en)
|
2012-05-30 |
2013-12-04 |
AmVac AG |
Method for expression of heterologous proteins using a recombinant negative-strand RNA virus vector comprising a mutated P protein
|
|
DK2898076T3
(en)
|
2012-09-19 |
2018-06-14 |
Dsm Ip Assets Bv |
METHOD OF CELL MODIFICATION USING ESSENTIAL GENES AS MARKERS AND EVEN RECYCLING THESE
|
|
CN104919048B
(zh)
*
|
2012-10-01 |
2018-10-26 |
台北荣民总医院 |
制备诱导多能干细胞的方法及其应用
|
|
EP2907870A4
(en)
|
2012-10-09 |
2016-04-06 |
Hayashi Nakanobu |
REPROGRAMMING OF PEPTIDES AND USE THEREOF
|
|
KR20150087321A
(ko)
|
2012-11-21 |
2015-07-29 |
메르츠 파마 게엠베하 운트 코. 카가아 |
보툴리눔 신경독소 생물학적 활성의 결정을 위한 수단 및 방법
|
|
WO2014093574A1
(en)
|
2012-12-13 |
2014-06-19 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for altering cell phenotype
|
|
WO2014152607A2
(en)
|
2013-03-14 |
2014-09-25 |
University Of Massachusetts |
Dosage compensating transgenes and cells
|
|
EP3003350B1
(en)
|
2013-05-27 |
2018-02-21 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Targeted modulation of macrophages
|
|
US10076574B2
(en)
|
2013-10-25 |
2018-09-18 |
Wayne State University |
Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming
|
|
WO2015077498A1
(en)
|
2013-11-20 |
2015-05-28 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for treating disorders of the eye
|
|
SG11201606934SA
(en)
|
2014-03-04 |
2016-09-29 |
Fate Therapeutics Inc |
Improved reprogramming methods and cell culture platforms
|
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
|
EP3194623B1
(en)
|
2014-08-12 |
2022-01-05 |
Wayne State University |
Systems and methods to detect stem cell stress and uses thereof
|
|
KR101663811B1
(ko)
|
2015-04-20 |
2016-10-11 |
연세대학교 산학협력단 |
뇌신경 질환의 예방 또는 치료용 약제학적 조성물
|
|
EP3286318A2
(en)
|
2015-04-22 |
2018-02-28 |
Mina Therapeutics Limited |
Sarna compositions and methods of use
|
|
US10428307B2
(en)
|
2015-04-29 |
2019-10-01 |
The Catholic University Of Korea Industry-Academic Cooperation Foundation |
Method for converting mesenchymal stem cells into endothelial cells by using specific transcription factors
|
|
EP3298141A4
(en)
|
2015-05-17 |
2019-01-09 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
|
|
EP3334755B1
(en)
|
2015-08-10 |
2020-04-08 |
Cellivery Therapeutics, Inc. |
Improved cell-permeable reprogramming factor (icp-rf) recombinant protein and use thereof
|
|
AU2016315703A1
(en)
|
2015-08-31 |
2018-03-08 |
The Trustees Of The University Of Pennsylvania |
Chimeric AAV-anti-VEGF for treating cancer in canines
|
|
US10429378B2
(en)
*
|
2015-09-15 |
2019-10-01 |
Board Of Supervisors Of Louisiana State University |
Methods of differentiating preadipocytes and uses thereof
|
|
WO2017173354A2
(en)
|
2016-04-01 |
2017-10-05 |
University Of Iowa Research Foundation |
METABOLICALLY STABILIZED DOUBLE STRANDED mRNA
|
|
EP3443001B1
(en)
|
2016-04-11 |
2025-04-30 |
Obsidian Therapeutics, Inc. |
REGULATED BIOCIRCUIT SYSTEMS
|
|
EP3452101A2
(en)
|
2016-05-04 |
2019-03-13 |
CureVac AG |
Rna encoding a therapeutic protein
|
|
US20190194756A1
(en)
|
2016-09-02 |
2019-06-27 |
Ruprecht-Karls-Universität Heidelberg |
Gene panel specific for pulmonary hypertension and its uses
|
|
EP3510145A4
(en)
|
2016-09-06 |
2020-03-25 |
The Children's Medical Center Corporation |
IMMUNCELLS FROM INDUCED PLURIPOTENT STEM CELLS
|
|
EP3385373A1
(en)
|
2017-04-05 |
2018-10-10 |
Centro de Neurociências e Biologia Celular |
Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof
|
|
US11339405B2
(en)
|
2017-04-12 |
2022-05-24 |
Academia Sinica |
Kit and method for producing induced embryonic neural progenitors
|
|
WO2018204764A1
(en)
|
2017-05-05 |
2018-11-08 |
Camp4 Therapeutics Corporation |
Identification and targeted modulation of gene signaling networks
|
|
WO2019023680A1
(en)
|
2017-07-28 |
2019-01-31 |
President And Fellows Of Harvard College |
METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
|
|
WO2019053012A1
(en)
|
2017-09-13 |
2019-03-21 |
Biontech Rna Pharmaceuticals Gmbh |
RNA REPLICON FOR THE REPROGRAMMING OF SOMATIC CELLS
|
|
JP2021502101A
(ja)
|
2017-11-10 |
2021-01-28 |
ハワード ヒューズ メディカル インスティチュート |
修飾されたリガンド依存性イオンチャネルおよび使用の方法
|
|
WO2019099552A1
(en)
|
2017-11-14 |
2019-05-23 |
The J. David Gladstone Institutes |
Methods of generating retinal pigment epithelium (rpe)
|
|
US11058729B2
(en)
|
2018-01-25 |
2021-07-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Exosomes and miRNA to treat glaucoma
|
|
KR102874471B1
(ko)
|
2018-03-05 |
2025-10-31 |
매사추세츠 아이 앤드 이어 인퍼머리 |
콜로니 자극 인자의 표적화에 의한 녹내장 및 시신경병증 치료법
|
|
WO2020012164A1
(en)
|
2018-07-13 |
2020-01-16 |
Ucl Business Ltd |
Glucocerebrosidase gene therapy
|
|
US12274733B2
(en)
|
2018-09-28 |
2025-04-15 |
President And Fellows Of Harvard College |
Cellular reprogramming to reverse aging and promote organ and tissue regeneration
|
|
MX2021003663A
(es)
|
2018-09-28 |
2021-05-28 |
Harvard College |
Reprogramacion celular para revertir el envejecimiento y promover la regeneracion de organos y tejidos.
|
|
CN113164625B
(zh)
*
|
2018-09-28 |
2026-04-14 |
哈佛大学的校长及成员们 |
用于基因表达的突变体反向四环素反式激活因子
|
|
WO2021183825A1
(en)
|
2020-03-12 |
2021-09-16 |
California Institute Of Technology |
Adeno-associated viral capsids with expanded sizes
|
|
AU2021236391A1
(en)
|
2020-03-13 |
2022-09-29 |
Capricor, Inc. |
Exosomal nucleic acid vaccine modularly configured to harness multiple antigen presentation mechanisms
|
|
US20210324414A1
(en)
|
2020-04-16 |
2021-10-21 |
Massachusetts Institute Of Technology |
Compositions and methods for sequestering viruses
|
|
MX2023012722A
(es)
|
2021-04-27 |
2023-11-08 |
Massachusetts Gen Hospital |
Capsides de aav y usos de las mismas.
|
|
US20240325568A1
(en)
|
2021-07-20 |
2024-10-03 |
The Broad Institute, Inc. |
Engineered targeting compositions for endothelial cells of the central nervous system vasculature and methods of use thereof
|
|
JP2025511883A
(ja)
|
2022-04-06 |
2025-04-16 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
中枢神経系の加齢を逆行させること
|